The Cigna Group (NYSE:CI) Shares Purchased by Solel Partners LP

Solel Partners LP boosted its holdings in shares of The Cigna Group (NYSE:CI - Free Report) by 37.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 148,400 shares of the health services provider's stock after purchasing an additional 40,100 shares during the quarter. The Cigna Group comprises about 8.0% of Solel Partners LP's investment portfolio, making the stock its 4th largest position. Solel Partners LP owned about 0.05% of The Cigna Group worth $40,979,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of CI. TCTC Holdings LLC bought a new stake in The Cigna Group in the fourth quarter worth about $25,000. Collier Financial bought a new position in The Cigna Group in the 4th quarter valued at $32,000. ORG Wealth Partners LLC purchased a new stake in The Cigna Group in the fourth quarter worth $34,000. Compagnie Lombard Odier SCmA bought a new stake in shares of The Cigna Group during the fourth quarter worth $37,000. Finally, Transce3nd LLC purchased a new stake in shares of The Cigna Group during the fourth quarter valued at $38,000. Institutional investors own 86.99% of the company's stock.

The Cigna Group Price Performance

NYSE CI traded down $1.76 during trading hours on Monday, hitting $332.99. 1,472,571 shares of the company's stock traded hands, compared to its average volume of 1,698,168. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The company has a market capitalization of $91.13 billion, a PE ratio of 27.21, a PEG ratio of 0.98 and a beta of 0.47. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The firm's 50-day moving average is $323.21 and its 200-day moving average is $309.60.

The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share for the quarter, beating the consensus estimate of $6.35 by $0.39. The firm had revenue of $65.45 billion for the quarter, compared to analysts' expectations of $60.39 billion. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The company's revenue was up 14.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.47 EPS. Equities analysts forecast that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 1.81%. The ex-dividend date of this dividend is Tuesday, June 3rd. The Cigna Group's dividend payout ratio (DPR) is presently 49.35%.

Insider Activity

In other The Cigna Group news, insider Nicole S. Jones sold 4,904 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the sale, the insider now owns 29,421 shares in the company, valued at $9,065,198.52. This represents a 14.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Noelle K. Eder sold 9,944 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the sale, the insider now owns 13,406 shares in the company, valued at $4,289,920. The trade was a 42.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 43,751 shares of company stock valued at $13,603,991. Company insiders own 0.70% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Barclays boosted their price objective on shares of The Cigna Group from $339.00 to $382.00 and gave the company an "overweight" rating in a research report on Monday. Oppenheimer dropped their target price on The Cigna Group from $400.00 to $375.00 and set an "outperform" rating on the stock in a research report on Friday, January 31st. Truist Financial raised their target price on shares of The Cigna Group from $375.00 to $385.00 and gave the company a "buy" rating in a research note on Friday, April 11th. Piper Sandler upped their price target on The Cigna Group from $348.00 to $374.00 and gave the stock an "overweight" rating in a research report on Monday. Finally, Robert W. Baird lowered their price objective on The Cigna Group from $388.00 to $362.00 and set an "outperform" rating for the company in a research report on Tuesday, April 15th. Two equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have issued a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Buy" and a consensus price target of $378.00.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.